The Impact of Statin Type on Hepatocellular Carcinoma Risk

In patients with chronic viral hepatitis, only lipophilic statin use, and not hydrophilic statin use, significantly lowered 10-year HCC risk.

Source link

Related posts

G Protein-Coupled Receptors are Dynamic Regulators of Digestion and Targets for Digestive Diseases


FDA approves Aemcolo for travelers’ diarrhea


Risk Factors for Gastric Cancer in Lynch Syndrome Patients


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy